Defunct Company
Total Trials
1
As Lead Sponsor
0
As Collaborator
Total Enrollment
20
NCT01535664
An Open Label, Proof of Concept Study to Evaluate the Effects of Dalfampridine Withdrawal on Gait and Balance Parameters in Subjects With Multiple Sclerosis (MS)
Phase: N/A
Role: Collaborator
Start: Jan 31, 2012
Completion: Jun 30, 2012